CAR-macrophage versus CAR-T for solid tumors: The race between a rising star and a superstar.

Chen K, Liu ML, Wang JC, Fang S

DOI: 10.17305/bb.2023.9675
Published: 2024 May 2
Container: Biomolecules & biomedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.17305/bb.2023.9675,
  title = {CAR-macrophage versus CAR-T for solid tumors: The race between a rising star and a superstar.},
  author = {Chen K and Liu ML and Wang JC and Fang S},
  year = {2024},
  journal = {Biomolecules \& biomedicine},
  doi = {10.17305/bb.2023.9675},
  url = {https://doi.org/10.17305/bb.2023.9675}
}

RIS

TY  - JOUR
TI  - CAR-macrophage versus CAR-T for solid tumors: The race between a rising star and a superstar.
AU  - Chen K
AU  - Liu ML
AU  - Wang JC
AU  - Fang S
PY  - 2024
JO  - Biomolecules & biomedicine
DO  - 10.17305/bb.2023.9675
UR  - https://doi.org/10.17305/bb.2023.9675
ER  -

APA

K, C., ML, L., JC, W., & S, F. (2024). CAR-macrophage versus CAR-T for solid tumors: The race between a rising star and a superstar.. Biomolecules & biomedicine. https://doi.org/10.17305/bb.2023.9675

Source records

pubmed · retrieved 2026-11-10T07:40:48.951Z